tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Dev Prasad, 1 are a BUY (100%).
Analyst Dev Prasad, currently employed at LUCID CAPITAL, carries an average stock price target met ratio of 100% that have a potential upside of 387.8% achieved within 242 days.
Dev Prasad’s has documented 2 price targets and ratings displayed on 1 stocks.
Most recent stock forecast was given on CUE, Cue Biopharma at 25-Aug-2025.
Analyst best performing recommendations are on CUE (CUE BIOPHARMA).
The best stock recommendation documented was for CUE (CUE BIOPHARMA) at 8/25/2025. The price target of $4 was fulfilled within 242 days with a profit of $3.18 (387.8%) receiving and performance score of 16.02.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Aug-2025
$4
$-21.39 (-84.25%)
10 months 13 days ago
(25-Aug-2025)
1/1 (100%)
$3.18 (387.80%)
242
Buy Since 22-Jan-2020
$2
$-23.39 (-92.12%)
$2
1 years 2 months 23 days ago
(15-Apr-2025)
7/7 (100%)
$1.2 (150.00%)
714
Buy Since 13-Mar-2024
$4
$-21.39 (-84.25%)
$6
1 years 7 months 23 days ago
(15-Nov-2024)
2/2 (100%)
$2.75 (220.00%)
649
Buy Since 09-Apr-2020
$4
$-21.39 (-84.25%)
$8
1 years 10 months 18 days ago
(20-Aug-2024)
4/4 (100%)
$3.14 (365.12%)
700
Buy Since 21-Nov-2022
$3
$-22.39 (-88.18%)
$3
1 years 10 months 18 days ago
(20-Aug-2024)
5/5 (100%)
$2.14 (248.84%)
839
What Year was the first public recommendation made by Dev Prasad?
